The legacy of Viagra and its parent , copyright, presents a fascinating picture for potential investors. While the blockbuster drug initially fueled enormous revenues , its protection has ended, leading to generic alternatives flooding the landscape . This decline in value presents a substantial obstacle for copyright and any portfolio considering